SRC and cancer: Furthermore, Liu and colleagues reported in 2008 that blocking the interaction between Src and the NMDA receptor complex with a peptide mimicking the amino acid sequence of the unique domain of Src ameliorates inflammatory and neuropathic pain32, 33 and recently Felice et al. reported that the multi-kinase inhibitor saracatinib inhibits thermal hyperalgesia in cancer-induced bone pain34.